エピソード

  • Ep.99 – Unexpected Findings: Ertapenem in Surgical Prophylaxis
    2024/11/08
    Episode Notes

    For this episode, Dr. Libby Dodds Ashley is joined by Dr. Chris Hostler to discuss Dr. Hostler’s recent article evaluating postoperative outcomes in patients receiving ertapenem for colon surgery. This article that includes some data from our DASON sites so this is a MUST listen! The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/39363596/

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    続きを読む 一部表示
    15 分
  • Ep.98 – Choosing Wisely: Antibiotic Decisions in Outpatient Community-Acquired Pneumonia
    2024/10/25

    Join Dr. Angelina Davis as she discusses a recent article in Clinical Infectious Diseases on differences in outpatient community-acquired pneumonia treatment regimens. the article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/39442057/

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    続きを読む 一部表示
    19 分
  • Ep.97 – A Multicenter Retrospective Study Evaluating Intravenous to Oral Antibiotic Stepdown for Uncomplicated Streptococcal Bacteremia
    2024/10/11
    Episode Notes

    In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison Dr. Melissa Johnson reviews an article that compares the efficacy and safety of intravenous (IV) versus oral (PO) stepdown therapy for uncomplicated streptococcal bacteremia. The article can be found here: https://academic.oup.com/ofid/article/11/7/ofae361/7701251

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    続きを読む 一部表示
    26 分
  • Ep.96 – Update Alert! IDSA Resistant Gram-negative Guidance Version 4.0
    2024/09/27
    Episode Notes

    In this episode, Dr. Jeannette Bouchard and guest Dr. Emily Heil walk listeners through key updates to the IDSA Resistant Gram-negative Guidance and what may be most pertinent for our community partners. The materials reviewed today can be found here: https://www.idsociety.org/practice-guideline/amr-guidance/#UpdateHistory

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    続きを読む 一部表示
    38 分
  • Waiting on a Culture: Impact of pharmacist-led microresult follow-up post-discharge
    2024/09/13
    Episode Notes

    In this episode, Dr. April Dyer discusses a recent article in Antimicrobial Stewardship and Hospital Epidemiology on how pharmacists can help with post-hospital discharge micro result review. The article reviewed in today's episode can be found here: https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/impact-of-pharmacistled-microbiology-result-followup-postdischarge-for-patients-undergoing-inpatient-infectious-diseases-consultation/ED155B2C10D145480228E715ABCFB000

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    続きを読む 一部表示
    19 分
  • Ep.94 – Rethinking Daptomycin Dosing: New data on fixed dose daptomycin
    2024/08/30
    Episode Notes

    Join DASON Clinical Pharmacist Dr. Libby Dodds Ashley as she discusses a recent article in Pharmacotherapy on daptomycin dosing with one of the primary authors, Dr. Katie Olney. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/39078247/

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    続きを読む 一部表示
    18 分
  • Ep.93 – Return of the Penicillin Allergy Label
    2024/08/20
    Episode Notes

    In this exciting episode, DASON Clinical Pharmacist Dr. April Dyer discusses a hot off the press article that follows up the results from the big PALACE trial that was published in 2023. The article reviewed in this episode can be found here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822413

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    続きを読む 一部表示
    12 分
  • Ep.92 – Is One Better Than the Other? Analyzing surrogates for oral cephalosporin susceptibilities
    2024/08/02
    Episode Notes

    In this exciting episode, Dr. Jeannette Bouchard is joined by Drs. Katie Lambert and Catessa Howard to discuss their newly published brief report in OFID that helps shine a light on a common clinical issue, is cefazolin or ceftriaxone a better surrogate for third generation oral cephalosporins.

    The article reviewed in this episode can be found here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245689/

    For more information about DASON, please visit: https://dason.medicine.duke.edu/

    続きを読む 一部表示
    26 分